short to mid term targets

blokes;

You are giving away your book. That means you are only left with 700k. So you have sold the lions share. Don't get too carried away with ECQ. Well done anyway.

I myself am enjoying buying oppies at a 16 cent discount to ords, exercising (normally in 140k lots) and selling the ords for a 4 to 6 cent turn around i.e. 18-20 cents above the oppies purchase price. Currently the company is taking more than a week to issue shares after receiving option exercise.

I have so far sold 20% of holding. My short term target i.e. next 3 weeks 90-95 cent level. Then we should get a 2-3 week consolidation between 85 & 95 cents, then ....

If Aussie launch goes well without any major hickups, we can expect share price will get a MOVE along after mid October. We should be trading then well above $1.

Upon FDA approval we could see stock price take-off to between $1.50 and $2. Timing of FDA approval is very tricky. It could take as long as mid January but I am hoping that due to all meetings & guidances given by the FDA we could get approval by early to mid December. Succesful launch in Australia will help along FDA approval along.

Exciting weeks (and months)ahead with expected announcements of distributorship tie-ups and marketing associated with Aussie launch.

In getting ready for U.S. launch I would expect additional top notch sales & marketing personnel with proven success record being employed by the company.

If we get FDA approval by mid December and a successful launch, I would hate to guess where the share price will be in 6 months i.e. March 2014.

Do not discount $3 plus moving towards a $1 billion market cap. That is still a whopping 400-500% return from todays levels.